Amgen, Thermo Fisher and PepsiCo headline Zacks??? latest research, with growth drivers, raised outlooks and key risks in focus.

Thermo Fisher stock trades above its consensus target while Q2 2026 revenue and earnings growth, plu

Thermo Fisher has rallied roughly 45% off its May low to sit near record highs at about 34 times earnings. A completed $1.075 billion divestiture and a well-timed buyback sharpened the story.

Premium healthcare stocks often trade at elevated valuations for very different reasons. Thermo Fisher’s (NYSE:TMO) investment case increasingly depends on whether the life sciences industry is emerging from its post-pandemic slowdown, while Intuitive Surgical (NASDAQ:ISRG) continues to hold a dominant position in robotic surgery through factors such as its highly recurring revenue model. Both companies […]

Las acciones de Thermo Fisher cotizan por encima de los 629 dólares por acción al 21 de agosto de 2026, con sólidos ingresos en el segundo trimestre de 2026.

Portfolio Design Labs LLC compró una nueva posición en acciones de Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) durante el segundo trimestre, según su presentación más reciente del Formulario 13F ante la Comisión de Bolsa y Valores (SEC). La empresa compró 3.046 acciones de la investigación médica comp